Overview
Inverted Formin 2 (INF2) is a member of the formin family of actin-nucleating proteins encoded by the INF2 gene located on chromosome 14q11.2. Formins are conserved cytoskeletal regulatory proteins that nucleate and elongate actin filaments, fundamental structures for numerous cellular processes including cell motility, division, and intracellular trafficking. INF2 is distinguished by its unique structural organization and bidirectional actin polymerization capability, making it functionally distinct from canonical formin family members. The protein contains a characteristic formin homology domain (FH2) flanked by formin homology 1 (FH1) domains, though its inverted domain architecture differs from typical formins. INF2 has emerged as a critical regulator in neuronal health and axonal maintenance, with particular relevance to neurodegenerative disease pathogenesis.
Function and Biology
INF2 regulates actin dynamics through its capacity to both nucleate and depolymerize actin filaments depending on cellular context and protein interactions. The protein localizes to multiple subcellular compartments including the perinuclear region, mitochondria, and endoplasmic reticulum (ER), where it coordinates complex actin networks essential for organelle positioning, trafficking, and morphological integrity. At mitochondria, INF2 participates in actin assembly that facilitates mitochondrial fission and movement through the cytoplasm. Within neuronal cells, INF2 is particularly enriched in axons and growth cones, where precise actin regulation is essential for axonal elongation, guidance, and synaptic remodeling.
INF2 activity is tightly controlled through multiple regulatory mechanisms, including autoinhibition via its C-terminal region and modulation by Rho family GTPases, particularly Cdc42 and Rac1. Phosphorylation events mediate INF2 activation in response to various cellular signals. The protein interacts with numerous binding partners including mitochondrial dynamics regulators like DRP1 (dynamin-related protein 1) and membrane trafficking factors, establishing INF2 as an integration point between cytoskeletal dynamics, organellar function, and cell signaling.
Role in Neurodegeneration
Mutations in INF2 are causally linked to Charcot-Marie-Tooth disease type 2O (CMT2O), an autosomal dominant inherited peripheral neuropathy characterized by progressive distal muscle weakness and sensory loss. CMT2O-associated INF2 mutations impair normal actin regulation, leading to disrupted axonal transport, compromised mitochondrial function, and eventual axonal degeneration. The selective vulnerability of long peripheral axons to INF2 dysfunction reflects their heightened dependence on mitochondrial ATP and active transport systems for maintenance.
Beyond CMT2O, emerging evidence implicates dysregulated INF2 in broader neurodegenerative processes affecting Alzheimer's disease and Parkinson's disease pathogenesis. Aberrant actin polymerization and impaired mitochondrial dynamics—hallmarks of neurodegeneration—are associated with altered INF2 signaling. Amyloid-beta and alpha-synuclein, pathogenic proteins in Alzheimer's and Parkinson's disease respectively, may disrupt normal INF2-mediated actin regulation, thereby contributing to synaptic dysfunction and neuronal death.
Molecular Mechanisms
CMT2O-associated INF2 mutations predominantly localize to the FH2 domain or adjacent regulatory regions, disrupting actin nucleation capacity or altering protein stability. These mutations generate hyperactive variants that promote excessive actin polymerization and anomalous mitochondrial fission, or loss-of-function variants that impair essential actin networks. Either scenario compromises axonal integrity through multiple mechanisms: impaired axonal transport of mitochondria and cargo, reduced ATP availability, accumulation of dysfunctional mitochondria, and ultimately activation of axonal degeneration pathways including calcium dysregulation and calpain-mediated protein degradation.
At the molecular level, INF2 dysfunction disrupts the coordinated actin-mitochondrial interaction network essential for normal neuronal function. Abnormal mitochondrial positioning compromises local ATP delivery to energy-demanding axonal regions, including nodes of Ranvier and synaptic terminals, precipitating bioenergetic crisis.
Clinical and Research Significance
INF2 mutations have been identified in multiple CMT2O families worldwide, establishing definitive genetic association with neurodegeneration. Research increasingly focuses on INF2-targeted therapeutic strategies, including small molecules modulating formin activity and genetic rescue approaches. Understanding INF2 dysfunction illuminates fundamental mechanisms linking cytoskeletal dysregulation to axonal degeneration, with potential implications for broader neurodegenerative disease treatment.
- Formin Family: mDia1, mDia2, INF1
- Cytoskeletal Regulators: Cdc42, Rac1, RhoA
- Mitochondrial Dynamics: DRP1, OPA1, MFN2
- CMT2O-Related Genes: